St. Joseph’s Health Enhances Provider Communications with careMESH’s Healthcare Directory and User-Friendly Messaging Services
New Jersey-based St. Joseph’s Health partners with careMESH to significantly expand the health system’s clinical communications reach to all community physicians, including digital access to electronic medical records. Using careMESH, St. Joseph’s will focus on several key areas, including:
Streamlining external communications with community physiciansReducing
Read More
Science 37
Science 37, physIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices
What You Should Know:
- Science 37, a leader in agile clinical trials, and physIQ Inc, a leader in digital medicine, announced their alliance to help researchers use remote biosensors and machine learning to build more robust data sets.
- The partnership will help boost the number of digital biomarkers and generate insights from continuous data streams to indicate the safety and efficacy of new clinical treatments more quickly and objectively.
Read More
Analysis: August Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020.
M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
Science 37 Raises $31M to Expand Virtual Clinical Trail Model
Science 37, Inc., a LosAngeles-based mobile technology and clinical trial startup that focuses on the development of networked patient-centric models for clinical research has raised $31 million in Series B funding led by Redmile Group. The Series B round also includes participation from Series A lead investors Lux Capital and dRx Capital, as well as a strategic investment from Sanofi Genzyme BioVentures. As part of the strategic investment, Sanofi’s international clinical trial development
Read More
